Allergan Inc., an industry leader in pharmaceuticals and medical devices, has released a public statement separating itself from the Poly Implant Prosthese (PIP) breast implant scandal which is currently under investigation in Europe. Allergan, maker of popular breast implant products such as NATRELLE, McGhan and CUI, is in no way affiliated with PIP and seeks to reassure patients and surgeons that Allergan products are of the highest quality and safety.
Allergan breast implant devices have been successfully on the market for almost 50 years. The products are available in over 60 countries and are subjected to rigorous national and international quality control standards and practices.
Among the many products manufactured by Allergan every year, silicone gel-filled breast implants are by far the most favored among both patients and surgeons. The gel-filled implants have been placed in more than 1 million women worldwide.
As a result of hundreds of thousands of clinical trials, peer-reviewed journals and published reports, silicone gel-filled breast implants have become one the most studied devices in the world. Allergan’s gel-filled implants specifically, have set themselves apart from various competitors due to their more cohesive silicone gel and their stronger outer shells.
A recent report published by the U.S. FDA has again confirmed the safety and effectiveness of silicone breast implants when used as intended, however, it is important for patients to recognize that breast implants are not made for lifelong use. Patients at some point in their lives may require a removal and replacement. Breast implants should be monitored regularly by a physician.
Allergan is committed to excellence and continues to set the industry standard for breast implant manufacturing with their strong adherence to the most stringent of safety and quality standards.
Learn more about gel-filled breast implants in Detroit.